Bank Of America Corp Vascular Biogenics Ltd. Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.15 - $2.1 $441 - $6,174
-2,940 Reduced 26.41%
8,192 $1,000
Q2 2022

Aug 12, 2022
BUY
$1.22 - $1.95 $501 - $801
411 Added 3.83%
11,132 $17,000
Q1 2022

May 16, 2022
BUY
$1.15 - $1.97 $2,908 - $4,982
2,529 Added 30.87%
10,721 $18,000
Q2 2021

Sep 13, 2021
BUY
$1.69 - $2.67 $13,844 - $21,872
8,192 New
8,192 $19,000

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email